NITIN POTHEN: Open Payments
NPI 1821550948 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 90 payments from 17 companies in 2025. Trend: 2023 $331 · 2024 $1,226 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $748 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Alkermes, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Corium, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
Products named: VRAYLAR, SPRAVATO, COBENFY, FANAPT, INGREZZA, ARISTADA, REXULTI, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
